Pharma Pricing Strategies (BALS)

Venue: Radisson SAS

Location: Rome, Italy

Event Date/Time: Jan 16, 2007 End Date/Time: Jan 17, 2007
Report as Spam


With the EU growing in size and processes and decisions becoming more inter-related, pricing and cost containment strategies are becoming a complex issue. Price determines the profit. All R&D and marketing departments’ efforts can lose their effect if the price is not set correctly. It is also important to differentiate the price according to the purchasing power of the market. Detailed knowledge of the market is therefore crucial.
Do you want to maximize your profits by setting the optimum price? Are you using the correct pricing strategies for the given market? Does your price represent the value of your drug?
This event brings together a powerful group of Pharma pricing experts who will discuss how to connect the right pricing strategy to a specific drug. Attending this conference gives you a unique chance to learn how to increase your profits by having consumer and market friendly prices.

Key Speakers:
Zinta Krumins, General Manager, Boehringer-Ingelheim Turkey
Vince Thomas, New product Pricing & Health Economics and Outcomes Research, Novartis
Patrick Mollon, Senior Associate Director, Worldwide Outcomes Research, Pfizer
Raphael De Wilde, Vice President Health Economics & Pricing Biopharm, Johnson & Johnson
Asa Kornfled, Head of Department of International Pricing & Reimbursement, Economics & Pricing Division, Lundbeck SAS France

Key topics:
Step into 2007 informed about newest Pricing and Reimbursement Criteria in the Main EU markets
Be ahead of competition and secure success by obtaining market access
Hear about governmental price controls and be well prepared
Join our strategic search for the price that expresses the value of the drug
Find a correct price for orphan drugs